Finasteride works for 85-90% of men, but a meaningful subset see little benefit. The diagnostic question is stabilization, not regrowth. The evaluation window is 24 months, not 6. Here is the responder framework.
DHT detox is not a real biological process. The hair supplements selling that promise are mostly weak saw palmetto plus marketing ingredients. Here is what the labels actually contain and where these products fit.
Topical dutasteride is the workaround everyone thinks they want. The half-life is the catch. Here is what the published evidence actually shows and where it actually fits.
RU58841 has thousands of user reports but no published Phase 2 or Phase 3 data. The honest read on the molecule, the legal landscape, the sourcing problem, and where it actually fits in 2026.
Pyrilutamide is the most-watched topical hair-loss compound in years, but the Phase 3 results were not what the early hype implied. Here is the honest read on KX-826 trial data, mechanism, and where it fits.
Diffuse thinning and AGA shed hair the same way but have completely different causes and treatments. Pattern is the diagnostic key. Here is how to tell them apart and what to do about each.
Mirror checks lie. Cameras under controlled conditions do not. The four-variable photo protocol that lets you read your own hair loss progress accurately.
The Norwood scale is the working clinical map of male pattern hair loss. Different stages call for different treatment intensities. Reading your stage and trajectory correctly is the first move.
A hair transplant works under four specific conditions. Stable AGA, adequate donor, realistic expectations, ongoing medical therapy.
Hair cloning has been five years away for the last twenty. Honest 2026 read on Stemson, dNovo, Pelage PP405, HairClone, Replicel, and the Tsuji lab. Plan accordingly.